Development and Validation of the Morphea Activity Measure in Patients With Pediatric Morphea.

ABSTRACT:

Importance

Morphea is an insidious inflammatory disorder of the skin and deeper tissues. Determining disease activity is challenging yet important to medical decision-making and patient outcomes.

Objective

To develop and validate a scoring tool, the Morphea Activity Measure (MAM), to evaluate morphea disease activity of any type or severity that is easy to use in clinical and research settings.

Design, setting, and participants

This pilot diagnostic study was conducted from September 9, 2019, to March 6, 2020, in 2 phases: development and validation. During the development phase, 14 morphea experts (dermatologists and pediatric dermatologists) used a Delphi consensus method to determine items that would be included in the MAM. The validation phase included 8 investiga

SUBMITTER: Garcia-Romero MT 

PROVIDER: S-EPMC9909574 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature